Evolution of Direct Costs in the First Years of Rheumatoid Arthritis: Impact of Early versus Late Biologic Initiation - An Economic Analysis Based on the ESPOIR Cohort

OBJECTIVES: To estimate annual direct costs of early RA by resource component in an inception cohort, with reference to four distinct treatment strategies: no disease modifying antirheumatic drugs (DMARDs), synthetic DMARDs only, biologic DMARDs in the first year (‘first-year biologic’, FYB), and bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevreul, Karine, Haour, Georges, Lucier, Sandy, Harvard, Stephanie, Laroche, Marie-Laure, Mariette, Xavier, Saraux, Alain, Durand-Zaleski, Isabelle, Guillemin, Francis, Fautrel, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014570/
https://www.ncbi.nlm.nih.gov/pubmed/24811196
http://dx.doi.org/10.1371/journal.pone.0097077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014570/
https://www.ncbi.nlm.nih.gov/pubmed/24811196
http://dx.doi.org/10.1371/journal.pone.0097077

Ejemplares similares